A guide for life sciences entrepreneurs
Small companies face the same long product cycles and upfront costs as the big players but have different IP challenges, explains Chad Shear of Fish & Richardson.
Latest news
Groups urge Fed Circ to rehear Biogen patent case
18-01-2022
Pharma, biotech and chemical industry groups have asked the US Court of Appeals for the Federal Circuit to review its decision to invalidate a Biogen patent for lacking written description.
Regions
Sectors
